We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CSBR market cap is 109.51M. The company's latest EPS is USD -0.5262 and P/E is -14.79.
| Quarter End | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 | Oct 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 11.57M | 12.02M | 14M | 14.06M | 13.49M |
| Operating Income | -1.96M | -2.58M | 164k | 1.33M | 732k |
| Net Income | -2.07M | -2.53M | -109k | 1.31M | 728k |
| Year End 30 April 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 32.12M | 41.04M | 49.11M | 53.87M | 50.16M |
| Operating Income | -1.8M | 366k | 607k | -5.26M | -6.92M |
| Net Income | -1.98M | 362k | 548k | -5.34M | -7.28M |
| Quarter End | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 | Oct 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 28.29M | 26.79M | 26.13M | 24.93M | 25.24M |
| Total Liabilities | 28.2M | 28.85M | 28.04M | 25.27M | 24.56M |
| Total Equity | 93k | -2.06M | -1.9M | -332k | 681k |
| Year End 30 April 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 20.75M | 27.59M | 35.38M | 34.31M | 26.13M |
| Total Liabilities | 15.43M | 20.16M | 26.28M | 29.68M | 28.04M |
| Total Equity | 5.32M | 7.43M | 9.1M | 4.64M | -1.9M |
| Quarter End | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 | Oct 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.4M | -4.32M | -6.14M | 311k | 28k |
| Investing | -821k | -947k | -836k | N/A | -94k |
| Financing | -382k | -382k | -527k | -37k | 202k |
| Year End 30 April 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 2.91M | -1.68M | 6.5M | 3.97M | -6.14M |
| Investing | -2.22M | -3.17M | -2.38M | -2.87M | -836k |
| Financing | 4.42M | 1.2M | 207k | 11k | -527k |
| Market Cap | 109.51M |
| Price to Earnings Ratio | -14.79 |
| Price to Sales Ratio | 2.14 |
| Price to Cash Ratio | 41.1 |
| Price to Book Ratio | -56.53 |
| Dividend Yield | - |
| Shares Outstanding | 13.83M |
| Average Volume (1 week) | 30.16k |
| Average Volume (1 Month) | 41.19k |
| 52 Week Change | 55.91% |
| 52 Week High | 11.99 |
| 52 Week Low | 3.6001 |
| Spread (Intraday) | 1.1 (13.75%) |
| Company Name | Champions Oncology Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.championsoncology.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
